Pertussis: old foe, persistent problem

Camille Sabella1

  • 1Division of Pediatrics, Section of Pediatric Infectious Diseases, The Children's Hospital, The Cleveland Clinic Foundation, OH 44195, USA. sabellc@ccf.org

Insights

Pertussis, or whooping cough, remains a significant health threat despite available vaccines. Waning immunity in older individuals creates reservoirs of infection, endangering infants who contract the disease from them.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Pertussis (whooping cough) poses a continued risk for severe illness and death, even with existing vaccines.
  • Immunity from pertussis infection or vaccination diminishes within approximately five years.
  • Older children, adolescents, and adults serve as crucial reservoirs for pertussis transmission, often with mild or unrecognized symptoms.

Purpose of the Study:

  • To highlight the ongoing public health challenge posed by pertussis.
  • To emphasize the role of waning immunity in disease transmission.
  • To underscore the vulnerability of infants to severe pertussis complications.

Main Methods:

  • This is a conceptual review based on existing epidemiological data and immunological principles.
  • Analysis of pertussis epidemiology, vaccine efficacy, and duration of immunity.
  • Identification of transmission dynamics from older populations to vulnerable infants.

Main Results:

  • Pertussis incidence remains significant due to waning immunity.
  • Adolescents and adults with diminished immunity act as primary sources for infant infections.
  • Infants are at high risk for severe pertussis, including life-threatening complications.

Conclusions:

  • Expanding immunization programs to include adolescents and adults caring for infants is critical.
  • Strategies to bolster immunity in older populations are needed to protect vulnerable infants.
  • Public health efforts must address the cycle of pertussis transmission from reservoirs to neonates.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...